Significance of alterations in plasma lipid profile levels in breast cancer

Integrative Cancer Therapies

Volumn 7, Issue 1, 2008, Pages 33-41

  Shah, Franky Dhaval ^a   Shukla, Shilin Nandubhai ^a   Shah, Pankaj Manubhai ^a   Patel, Hiten R H ^b   Patel, Prabhudas Shankerbhai ^a  

^a GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Cholesterol; Lipid profile; Lipoproteins; Plasma; Triglycerides

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BODY MASS; BREAST CANCER; BREAST DISEASE; CANCER RISK; CONTROLLED STUDY; DEMOGRAPHY; EARLY CANCER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MENOPAUSE; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK ASSESSMENT; SPECTROPHOTOMETRY; STATISTICAL ANALYSIS;

EID: 39049114042     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735407313883     Document Type: Article

References (38)

1. Parkin DM, Freddie B., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005 ; 55: 74-108.
2. Agarwal SP, Rao YN, Gupta S, eds. Fifty Years of Cancer Control in India. New Delhi, India: Ministry of Health and Family Welfare ; 2002.
3. Annual Report of Population Based Cancer Registry and Hospital Based Cancer Registry. Ahmedabad, India: The Gujarat Cancer & Research Institute ; 2001.
4. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol. 2001 ; 2: 133-140.
5. McPherson K., Steel CM, Dixon JM Breast cancer-epidemiology, risk factors, and genetics. BMJ. 2000 ; 321: 624-628.
6. Shields PG, Harris CG Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol. 2000 ; 18: 2309-2315.
7. Ambrosone CB Oxidants and antioxidants in breast cancer. Antioxid Redox Signal. 2000 ; 2: 903-917.
8. Brown NS, Roy B. Hypoxia and oxidative stress in breast cancer oxidative stress: its effects on the metastatic potential and response to therapy of breast cancer. Breast Cancer Res. 2001 ; 3: 323-327.
9. Halliwell B., Cutteridge JMC. Free Radical Biology and Medicine. 3 rd ed. Oxford, UK: Oxford University Press ; 1999.
10. Irshad M., Chaudhuri PS Oxidant-antioxidant system: role and significance in human body. Ind J Exp Biol. 2002 ; 40: 1233-1239.
11. Klaunig JE, Kamendulis LM The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol. 2004 ; 44: 239-267.
12. Girotti AW Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res. 1998 ; 39: 1529-1542.
13. Hasija K., Bagga HK Alterations of serum cholesterol and serum lipoprotein in breast cancer of women. Ind J Clin Biol. 2005 ; 20: 61-66.
14. Holmes MD, Hunter DJ, Colditz GA, Stampfer MJ, Hankinson SE Association of dietary intake of fat and fatty acids with risk of breast cancer. J Am Med Assoc. 1999 ; 281: 914-920.
15. Ray G., Husain SA Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem. 2001 ; 34: 71-76.
16. Gaziano JM, Hennekens CH Dietary fat and risk of prostate cancer prostate. J Natl Cancer Inst. 1995 ; 87: 1427-1428.
17. Steinmetz KA, Potter JD Egg consumption and cancer of the colon and rectum. Eur J Cancer Prev. 1994 ; 3: 237-245.
18. Howe GR, Aronson KJ, Benito E., et al. The relationship between dietary fat intake and risk of colorectal cancer: evidence from the combined analysis 13 case-control studies. Cancer Causes Control. 1997 ; 8: 215-228.
19. Siemianowicz K., Gminski J., Stajszczyk M., et al. Serum total cholesterol and triglycerides levels in patients with lung cancer. Int J Mol Med. 2000 ; 5: 201-205.
20. Fiorenza AM, Branchi A., Sommariva D. Serum lipoprotein profile in patients with cancer: a comparison with non-cancer subjects. Int J Clin Lab Res. 2000 ; 30: 141-145.
21. Moschovi M., Trimis G., Apostolakou F., Papassotiriou I., Tzortzatou-Stathopoulou F. Serum lipid alterations in acute lymphoblastic leukemia of childhood. J Pediatr Hematol Oncol. 2004 ; 26: 289-293.
22. Ray A., Jain D., Yadav R., et al. Effect of cancer treatment modalities on serum lipids and lipoproteins among women with carcinoma of the breast. Ind J Physiol Pharmacol. 2001 ; 45: 337-344.
23. Alexopoulos CG, Pournaras S., Vaslamatzis M., Avgerinos A., Raptis S. Changes in serum lipids and lipoproteins in cancer patients during chemotherapy. Cancer Chemother Pharmacol. 1992 ; 30: 412-416.
24. Miller AB, Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer. 1981 ; 47: 207-214.
25. Lane DM, Bootman KK, McConatty WJ Serum lipids and apolipoproteins in women with breast masses. Breast Cancer Res Treat. 1995 ; 34: 161-169.
26. Mady EA Association between estradiol, estrogen receptors, total lipids, triglycerides and cholesterol in patients with benign and malignant breast tumors. J Steroid Biochem Mol Biol. 2000 ; 75: 323-328.
27. Borrelli R., del Sordo G., De Filippo E., Contaldo F., Parisi V., Beneduce G. High serum HDL cholesterol in pre and post menopausal women with breast cancer in southern Italy. Adv Exp Med Biol. 1993 ; 348: 149-153.
28. Gonenc A., Erten D., Aslan S., Akinci M., Simsek B., Torun M. Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease. Cell Biol Int. 2006 ; 30: 376-380.
29. Kokoglu E., Karaarslan I., Karaarslan HM, Baloglu H. Alterations of serum lipids and lipoproteins in breast cancer. Cancer Lett. 1994 ; 82: 175-178.
30. Farid AA, Basiouny AE, Nagi AI, Abdelbaset AE Serum lipids and tissue DNA content in egyptian female breast cancer patients. Jpn J Clin Oncol. 2003 ; 33: 278-282.
31. Michalaki V., Koutroulis G., Syrigos K., Piperi C., Kalofoutis A. Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer. Mol Cell Biochem. 2005 ; 268: 19-24.
32. Hauser JM, Buehrer BM, Bell RM Role of ceramide in mitogenesis induced by exogenous sphingoid bases. J Biol Chem. 1994 ; 269: 6803-6809.
33. Hannun YA, Linardic CM Sphingolipid breakdown products: antiproliferative and tumor-suppresssor lipids. Biochim Biophys Acta. 1993 ; 1154: 223-236.
34. Kesaniemi YA, Witzlum JL, Heinbrecher UP Receptor-mediated catabolism of low density lipoprotein in man: quantitation using glycosylated lipoprotein. J Clin Invest. 1983 ; 71: 950-959.
35. Padayatty SJ, Katz A., Wang Y., et al. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr. 2003 ; 22 (1). 18-35.
36. Carbo N., Costelli P., Tessitore L. Anti-tumor necrosis factor treatment interferes with changes in lipid metabolism in a tumor cachexia model. Clin Sci. 1994 ; 87: 349-355.
37. Takatani O., Okumoto T., Kosano H. Genesis of breast cancer in Japanese: a possible relationship between sex hormone-binding globulin (SHBG) and serum lipid components. Breast Cancer Res Treat. 1991 ; 18: 527-529.
38. Gaard M., Tretli S., Urdal P. Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women. Cancer Causes Control. 1994 ; 6: 501-509.